We did not use the word "scam", but the company's long history of claiming progress with no actual progress made was worrisome to us. Our view was they were finally running "put up or shut up" trials that would provide an answer to whether they had something or were simply experts at separating shareholders from their money to continue collecting a salary.
FWIW, I agree with Dew that was a very bad PR.
Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr